Clarissa de Oliveira Ferreira is a medical student at Centro Universitário de Maceió (UNIMA-Afya), Brazil, with academic interests in obesity, metabolism, cardiometabolic medicine, and evidence-based medicine. Her complementary training includes Pharmaceutical Care for the Diabetic Patient, Myocardial Infarction at the University of Zurich, Anticoagulation at Universidad de Los Andes, and Hemostasis and Thrombosis from the Brazilian Association of Hematology, Hemotherapy and Cell Therapy. She has completed training in clinical laboratory interpretation and public health. Her academic work focuses on the use of semaglutide as adjunctive pharmacotherapy after bariatric surgery, particularly in the management of insufficient weight loss and weight recurrence.